Arul Prakash

Superior Performance of Newly Developed Alinity Anti‐HCV Next Assay in the Diagnosis of HCV Infection

Suresh Ponnuvel, Hussain Rasheed Ali, Arul Prakash, Runal John Steve et autres

(n = 195). Hepatitis C virus core antigen (HCVcAg) and HCV-RNA were quantified using Architect HCVcAg and Abbott real-time PCR, respectively. Performance on seroconversion and proficiency testing panels were assessed. Significant proportion of equivocal (99%) & low-positive (76.3%) samples were negative in …

in, us (code pays fourni par la source)

ARCHITECT HBsAg Next assay is positioned better to resolve and refine challenging weak reactive clinical samples

Arul Prakash, Suresh Ponnuvel, John Dickson Calvin Devadasan, Karthik Nithyanandhan et autres

in (code pays fourni par la source)

Longitudinal assessment of HCV core antigen kinetics to monitor therapeutic response in the age of DAAs

Suresh Ponnuvel, Arul Prakash, Runal John Steve, C. George Priya Doss et autres

BACKGROUND: In the economy of therapeutic monitoring, an affordable viral marker is essential in the era of direct-acting antivirals (DAAs). We elucidated the kinetics of HCVcAg to delineate its precise role in monitoring therapeutic response. METHODS: In this longitudinal study, 3208 patients …

in (code pays fourni par la source)

Versatile performance edges of HBsAg Next assay in diagnosis and therapeutic monitoring of HBV infection

Runal John Steve, Arul Prakash, Suresh Ponnuvel, Calvin John Dickson et autres

in (code pays fourni par la source)